Floatz logo

Amphetamine

Major Depression

Massachusetts General HospitalSmall moleculePhase 4 / ApprovedDormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Major Depression cohort.

Asset / SponsorPhaseRating
Risperdal
Johns Hopkins University
Phase 4BBB
Zelapar
Corium Innovations, Inc.
Phase 4BBB
Amitriptyline
e-Therapeutics PLC
Phase 4BBB
MELIPRAMINE
Hospital de Clinicas de Porto Alegre
Phase 4BBB
Xingpijieyu Formula
Peking University Sixth Hospital
Phase 4BB

View all 44 →

Same molecule, other indications

Amphetamine is also rated in:

DementiaDormant
B
Indicative ·
61 / 100
View asset →
Alzheimer DiseaseDormant
CCC
Indicative ·
55 / 100
View asset →
SchizophreniaDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →